Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Related records

Trials (83)

• A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.
• A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
• A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
• A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
• A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer
• A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis
• A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
• A Safety and Tolerability Study of Jaktinib
• A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
• A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
• A Study of Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
• A Study of Jaktinib Hydrochloride Tablets in the Treatment of Severe Novel Coronavirus Pneumonia
• A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
• A Study of ZG005 in Patients With Advanced Solid Tumors
• A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
• A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
• A Study of ZG2001 in Participants With KRAS Mutated Advanced Solid Tumours
• A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers
• A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
• A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata